Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 25, 2023

Primary Completion Date

February 2, 2024

Study Completion Date

February 2, 2024

Conditions

Healthy Elderly Subjects

Interventions

DRUG

ET-26HCl

The dose is 0.8 mg/kg, single dose, Infusion time was 60s ± 5s.

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province), Jinan